Comparison of cell therapy and cytokine therapy for functional repair in ischemic and nonischemic heart failure

Cell Transplantation

Volumn 16, Issue 4, 2007, Pages 365-374

  Li, Tao Sheng ^a,b   Mikamo, Akihito ^a   Takahashi, Masaya ^a   Suzuki, Ryo ^a   Ueda, Kazuhiro ^a   Ikeda, Yasuhiro ^a   Matsuzaki, Masunori ^a   Hamano, Kimikazu ^a  

^a YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Angiogenesis; Cell therapy; Cytokine therapy; Heart failure; Ischemia

Indexed keywords

DOXORUBICIN; SCATTER FACTOR; STEM CELL FACTOR; CYTOKINE; STEM CELL FACTOR RECEPTOR;

ANGIOGENESIS; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CONTROLLED STUDY; CORONARY ARTERY LIGATION; DRUG EFFECT; DRUG EFFICACY; FUNCTIONAL ASSESSMENT; HEART FAILURE; HEART FUNCTION; HEART MUSCLE CELL; HEART MUSCLE FIBROSIS; HEART MUSCLE ISCHEMIA; HEMATOPOIETIC STEM CELL TRANSPLANTATION; IMMUNOTHERAPY; LEFT ANTERIOR DESCENDING CORONARY ARTERY; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; SURVIVAL RATE; TRANSGENIC MOUSE; ANIMAL; BONE MARROW TRANSPLANTATION; COMPARATIVE STUDY; DISEASE MODEL; HEART MUSCLE; METABOLISM; PATHOLOGY;

MUS;

ANIMALS; APOPTOSIS; BONE MARROW TRANSPLANTATION; CYTOKINES; DISEASE MODELS, ANIMAL; HEART FAILURE; HEPATOCYTE GROWTH FACTOR; MICE; MYOCARDIAL ISCHEMIA; MYOCARDIUM; PROTO-ONCOGENE PROTEINS C-KIT;

EID: 38349054809     PISSN: 09636897     EISSN: None     Source Type: Journal    
DOI: 10.3727/000000007783464858     Document Type: Article

References (29)

1. Balsam, L. B.; Wagers, A. J.; Christensen, J. L.; Kofidis, T.; Weissman, I. L.; Robbins, R. C. Haematopoietic stem cells adopt mature haematopoietic fates in ischaemic myocardium. Nature 428:668-673; 2004.
2. Fedak, P. W.; Szmitko, P. E.; Weisel, R. D.; Altamentova, S. M.; Nili, N.; Ohno, N.; Verma, S.; Fazel, S.; Strauss, B. H.; Li, R. K. Cell transplantation preserves matrix homeostasis: A novel paracrine mechanism. J. Thorac. Cardiovasc. Surg. 130:1430-1439; 2005.
3. Fuchs, S.; Satler, L. F.; Kornowski, R.; Okubagzi, P.; Weisz, G.; Baffour, R.; Waksman, R.; Weissman, N. J.; Cerqueira, M.; Leon, M. B.; Epstein, S. E. Catheter-based autologous bone marrow myocardial injection in no-option patients with advanced coronary artery disease: A feasibility study. J. Am. Coll. Cardiol. 41:1721-1724; 2003.
4. Grines, C. L.; Watkins, M. W.; Mahmarian, J. J.; Iskandrian, A. E.; Rade, J. J.; Marrott, P.; Pratt, C.; Kleiman, N.; Angiogene GENe Therapy (AGENT-2) Study Group. A randomized, double-blind, placebo-controlled trial of Ad5FGF-4 gene therapy and its effect on myocardial perfusion in patients with stable angina. J. Am. Coll. Cardiol. 42:1339-1347; 2003.
5. Hamano, K.; Li, T. S.; Kobayashi, T.; Hirata, K.; Yano, M.; Kohno, M.; Matsuzaki, M. Therapeutic angiogenesis induced by local autologous bone marrow cell implantation. Ann. Thorac. Surg. 73:1210-1215; 2002.
6. Hamano, K.; Nishida, M.; Hirata, K.; Mikamo, A.; Li, T. S.; Harada, M.; Miura, T.; Matsuzaki, M.; Esato, K. Local implantation of autologous bone marrow cells for therapeutic angiogenesis in patients with ischemic heart disease: Clinical trial and preliminary results. Jpn. Circ. J. 65:845-847; 2001.
7. Iwasaki, M.; Adachi, Y.; Nishiue, T.; Minamino, K.; Suzuki, Y.; Zhang, Y.; Nakano, K.; Koike, Y.; Wang, J.; Mukaide, H.; Taketani, S.; Yuasa, F.; Tsubouchi, H.; Gohda, E.; Iwasaka, T.; Ikehara, S. Hepatocyte growth factor delivered by ultrasound-mediated destruction of microbubbles induces proliferation of cardiomyocytes and amelioration of left ventricular contractile function in doxorubicin-induced cardiomyopathy. Stem Cells 23:1589-1597; 2005.
8. Jackson, K. A.; Majka, S. M.; Wang, H.; Pocius, J.; Hartley, C. J.; Majesky, M. W.; Entman, M. L.; Michael, L. H.; Hirschi, K. K.; Goodell, M. A. Regeneration of ischemic cardiac muscle and vascular endothelium by adult stem cells. J. Clin. Invest. 107:1395-1402; 2001.
9. Jayasankar, V.; Woo, Y. J.; Pirolli, T. J.; Bish, L. T.; Berry, M. F.; Burdick, J.; Gardner, T. J.; Sweeney, H. L. Induction of angiogenesis and inhibition of apoptosis by hepatocyte growth factor effectively treats postischemic heart failure. J. Card. Surg. 20:93-101; 2005.
10. Kastrup, J.; Jorgensen, E.; Ruck, A.; Tagil, K.; Glogar, D.; Ruzyllo, W.; Botker, H. E.; Dudek, D.; Drvota, V.; Hesse, B.; Thuesen, L.; Blomberg, P.; Gyongyosi, M.; Sylven, C.; Euroinject One Group. Direct intramyocardial plasmid vascular endothelial growth factor-A165 gene therapy in patients with stable severe angina pectoris A randomized double-blind placebo-controlled study: The Euroinject One trial. J. Am. Coll. Cardiol. 45:982-988; 2005.
11. Kinnaird, T.; Stabile, E.; Burnett, M. S.; Lee, C. W.; Barr, S.; Fuchs, S.; Epstein, S. E. Marrow-derived stromal cells express genes encoding a broad spectrum of arteriogenic cytokines and promote in vitro and in vivo arteriogenesis through paracrine mechanisms. Circ. Res. 94:678-685; 2004.
12. Kocher, A. A.; Schuster, M. D.; Szabolcs, M. J.; Takuma, S.; Burkhoff, D.; Wang, J.; Homma, S.; Edwards, N. M.; Itescu, S. Neovascularization of ischemic myocardium by human bone-marrow-derived angioblasts prevents cardiomyocyte apoptosis, reduces remodeling and improves cardiac function. Nat. Med. 7:430-436; 2001.
13. Li, T. S.; Hayashi, M.; Ito, H.; Furutani, A.; Murata, T.; Matsuzaki, M.; Hamano, K. Regeneration of infarcted myocardium by intramyocardial implantation of ex vivo transforming growth factor-beta-preprogrammed bone marrow stem cells. Circulation 111:2438-2445; 2005.
14. Li, Y.; Takemura, G.; Kosai, K.; Yuge, K.; Nagano, S.; Esaki, M.; Goto, K.; Takahashi, T.; Hayakawa, K.; Koda, M.; Kawase, Y.; Maruyama, R.; Okada, H.; Minatoguchi, S.; Mizuguchi, H.; Fujiwara, T.; Fujiwara, H. Postinfarction treatment with an adenoviral vector expressing hepatocyte growth factor relieves chronic left ventricular remodeling and dysfunction in mice. Circulation 107:2499-2506; 2003.
15. Losordo, D. W.; Vale, P. R.; Symes, J. F.; Dunnington, C. H.; Esakof, D. D.; Maysky, M.; Ashare, A. B.; Lathi, K.; Isner, J. M. Gene therapy for myocardial angiogenesis: Initial clinical results with direct myocardial injection of phVEGF165 as sole therapy for myocardial ischemia. Circulation 98:2800-2804; 1998.
16. Makino, S.; Fukuda, K.; Miyoshi, S.; Konishi, F.; Kodama, H.; Pan, J.; Sano, M.; Takahashi, T.; Hori, S.; Abe, H.; Hata, J.; Umezawa, A.; Ogawa, S. Cardiomyocytes can be generated from marrow stromal cells in vitro. J. Clin. Invest. 103:697-705; 1999.
17. Murry, C. E.; Soonpaa, M. H.; Reinecke, H.; Nakajima, H.; Nakajima, H. O.; Rubart, M.; Pasumarthi, K. B.; Virag, J. I.; Bartelmez, S. H.; Poppa, V.; Bradford, G.; Dowell, J. D.; Williams, D. A.; Field, L. J. Haematopoietic stem cells do not transdifferentiate into cardiac myocytes in myocardial infarcts. Nature 428:664-668; 2004.
18. Nakamura, T.; Matsumoto, K.; Mizuno, S.; Sawa, Y.; Matsuda, H.; Nakamura, T. Hepatocyte growth factor prevents tissue fibrosis, remodeling, and dysfunction in cardiomyopathic hamster hearts. Am. J. Physiol. Heart Circ. Physiol. 288:H2131-2139; 2005.
19. Nygren, J. M.; Jovinge, S.; Breitbach, M.; Sawen, P.; Roll, W.; Hescheler, J.; Taneera, J.; Fleischmann, B. K.; Jacobsen, S. E. Bone marrow-derived hematopoietic cells generate cardiomyocytes at a low frequency through cell fusion, but not transdifferentiation. Nat. Med. 10:494-501; 2004.
20. Okabe, M.; Ikawa, M.; Kominami, K.; Nakanishi, T.; Nishimune, Y. 'Green mice' as a source of ubiquitous green cells. FEBS Lett. 407:313-319; 1997.
21. Orlic, D.; Kajstura, J.; Chimenti, S.; Jakoniuk, I.; Anderson, S. M.; Li, B.; Pickel, J.; McKay, R.; Nadal-Ginard, B.; Bodine, D. M.; Leri, A.; Anversa, P. Bone marrow cells regenerate infarcted myocardium. Nature 410:701-705; 2001.
22. Perin, E. C.; Dohmann, H. F.; Borojevic, R.; Silva, S. A.; Sousa, A. L.; Mesquita, C. T.; Rossi, M. I.; Carvalho, A. C.; Dutra, H. S.; Dohmann, H. J.; Silva, G. V.; Belem, L.; Vivacqua, R.; Rangel, F. O.; Esporcatte, R.; Geng, Y. J.; Vaughn, W. K.; Assad, J. A.; Mesquita, E. T.; Willerson, J. T. Transendocardial, autologous bone marrow cell transplantation for severe, chronic ischemic heart failure. Circulation 107:2294-2302; 2003.
23. Schumacher, B.; Pecher, P.; von Specht, B. U.; Stegmann, T. Induction of neoangiogenesis in ischemic myocardium by human growth factors: First clinical results of a new treatment of coronary heart disease. Circulation 97:645-650; 1998.
24. Simons, M.; Annex, B. H.; Laham, R. J.; Kleiman, N.; Henry, T.; Dauerman, H.; Udelson, J. E.; Gervino, E. V.; Pike, M.; Whitehouse, M. J.; Moon, T.; Chronos, N. A. Pharmacological treatment of coronary artery disease with recombinant fibroblast growth factor-2: Double-blind, randomized, controlled clinical trial. Circulation 105:788-793; 2002.
25. Strauer, B. E.; Brehm, M.; Zeus, T.; Kostering, M.; Hernandez, A.; Sorg, R. V.; Kogler, G.; Wernet, P. Repair of infarcted myocardium by autologous intracoronary mononuclear bone marrow cell transplantation in humans. Circulation 106:1913-1918; 2002.
26. Takahashi, M.; Li, T. S.; Suzuki, R.; Kobayashi, T.; Ito, H.; Ikeda, Y.; Matsuzaki, M.; Hamano, K. Cytokines produced by bone marrow cells can contribute to functional improvement of the infracted heart by protecting cardiomyocytes from ischemic injury. Am. J. Physiol. Heart Circ. Physiol. 291:H886-893; 2006.
27. Van Belle, E.; Witzenbichler, B.; Chen, D.; Silver, M.; Chang, L.; Schwall, R.; Isner, J. M. Potentiated angiogenic effect of scatter factor/hepatocyte growth factor via induction of vascular endothelial growth factor: The case for paracrine amplification of angiogenesis. Circulation 97:381-390; 1998.
28. Wang, Y.; Ahmad, N.; Wani, M. A.; Ashraf, M. Hepatocyte growth factor prevents ventricular remodeling and dysfunction in mice via Akt pathway and angiogenesis. J. Mol. Cell. Cardiol. 37:1041-1052; 2004.
29. Wollen, K. C.; Meyer, G. P.; Lotz, J.; Ringes-Lichtenberg, S.; Lippolt, P.; Breidenbach, C.; Fichtner, S.; Korte, T.; Hornig, B.; Messinger, D.; Arseniev, L.; Hertenstein, B.; Ganser, A.; Drexler, H. Intracoronary autologous bone-marrow cell transfer after myocardial infarction: The BOOST randomised controlled clinical trial. Lancet 364:141-148; 2004.